Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Nicole Labrosse currently holds 36,357 shares of HALOZYME THERAPEUTICS, INC. (HALO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Nicole Labrosse has been a net seller of HALO stock. They have purchased $0 and sold $3.9M worth of shares.
Nicole Labrosse's most recent insider trade was on Feb 23, 2026, when they sold 6,688 shares at $0.00 per share.
Nicole Labrosse serves as Executive at HALOZYME THERAPEUTICS, INC. (HALO). They have executed 58 insider transactions totaling $3.9M over their tenure at the company.
Nicole Labrosse holds the position of Executive at HALOZYME THERAPEUTICS, INC., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 4 years and currently hold a stake valued at $0.
Nicole Labrosse has shown a selling trading pattern, with $0 in total purchases and $3.9M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Nicole Labrosse was on Sep 10, 2025, when they sold $1.0M worth of HALO shares. This transaction involved 13,240 shares at $75.93 per share.
Nicole Labrosse currently owns 36,357 shares of HALOZYME THERAPEUTICS, INC. (HALO), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Nicole Labrosse's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Nicole Labrosse has 58 Form 4 filings on record as an insider at HALOZYME THERAPEUTICS, INC..
Set alerts for Nicole Labrosse and 40,000+ other insiders.